SCHEMBL8052780

SCHEMBL8052780

CC[C@]12CC[C@]3(O)c4ccc(OC)cc4CC[C@@H]3[C@@H]1CC[C@@H]2CC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 4/20 0.41
POLA1 P09884 2/20 0.38
CYP2C19 P33261 1/20 0.37
KDM1A O60341 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
MTNR1A P48039 3/20 0.35
MTNR1B P49286 2/20 0.35
ESR1 P03372 1/20 0.35
OPRK1 P41145 1/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HSD17B1 P14061 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NQO2 P16083 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8049873 0.86 PPARD (0.42) PPARDPOLA1CYP2C19KDM1AFFAR4
SCHEMBL8048882 0.86 PPARD (0.42) PPARDPOLA1CYP2C19KDM1AFFAR4
SCHEMBL8048886 0.86 PPARD (0.42) PPARDPOLA1CYP2C19KDM1AFFAR4
SCHEMBL8049867 0.86 PPARD (0.42) PPARDPOLA1CYP2C19KDM1AFFAR4
SCHEMBL8055650 0.84 LMNA (0.43) CYP2C19KDM1AMTNR1BESR1LMNA
SCHEMBL8038058 0.78 HSD17B1 (0.44) CYP2C19KDM1AMTNR1AMTNR1BLMNA
SCHEMBL7515670 0.77 PPARD (0.38) PPARDPOLA1CYP2C19FFAR4MTNR1A
SCHEMBL11671496 0.72 STS (0.60) POLA1ESR1LMNAMAPTHSD17B1
SCHEMBL11222251 0.72 STS (0.60) POLA1ESR1LMNAMAPTHSD17B1
SCHEMBL8048425 0.72 LMNA (0.56) CYP2C19KDM1AESR1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882735-B1 9 Alpha-hydroxy-8 alpha-estra-1,3,5(10)-trienes and a process for their preparation JENAPHARM GMBH (DE) 2000-04-19 EP disclosed
EP-0882735-A1 9 Alpha-hydroxy-8 alpha-estra-1,3,5(10)-trienes and a process for their preparation Jenapharm GmbH & Co. KG (DE) 1998-12-09 EP disclosed